Suppr超能文献

1990 - 2021年中国细菌抗菌药物耐药负担:全球疾病负担研究2021的系统分析

Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.

作者信息

Chen Yifei, Li Jinxi, Gong Yanhong, Yin Xiaoxv

机构信息

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, No. 13 Hangkong Road, Wuhan, Hubei, 430030, China.

出版信息

BMC Med. 2025 Sep 18;23(1):517. doi: 10.1186/s12916-025-04333-2.

Abstract

BACKGROUND

China is confronted with a severe burden of antimicrobial resistance (AMR), and to date, there has been no comprehensive estimate of the historical trend of the AMR burden in China.

METHODS

Data on AMR were collected by the Global Antimicrobial Resistance Burden study 1990-2021. Logistic regression, polynomial models, stacked ensemble models, spatiotemporal Gaussian regression models, and mixed-effects meta-regression models are incorporated into the modeling framework to fit the burden of AMR and estimate the number of deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR in two counterfactual scenarios.

RESULTS

In 2021, it was estimated that 711,852 (95% uncertainty interval [UI] (586,447-837,256) deaths were associated with bacterial AMR in China, including 160,268 (132,375-188,160) deaths attributable to bacterial AMR. From 1990 to 2021, the number of deaths attributable to AMR among children under 5 years old declined by 95%, while that among the elderly aged 65 and above increased by 68%. Among the 12 infectious syndromes, the top three with the largest number of deaths attributed to AMR in 2021 were bloodstream infections (74,119), lower respiratory tract infections (60,839), and peritoneal and intra-abdominal infections (11,827). Among them, bloodstream infections were the infectious syndrome with the greatest increase in the number of deaths during the study period. In 2021, the pathogen with the highest number of deaths attributed to AMR was Staphylococcus aureus (39,643), and the one with the greatest increase in attributed deaths was Staphylococcus aureus, with an increase of 20,774 (16,880-24,668). In 2021, the pathogen-drug combination causing the highest number of AMR-attributed deaths was methicillin-resistant Staphylococcus aureus (26,023), and the pathogen with the highest annualized rate of change in attributed deaths over 31 years was third-generation cephalosporin-resistant Acinetobacter baumannii (17.5%).

CONCLUSIONS

Bacterial antimicrobial resistance in China was a serious threat to public health, especially for elderly people. Meanwhile, intervention measures such as popularizing vaccination, reducing the misuse of antibiotics, and developing new antibiotics should be combined to address this significant health threat.

摘要

背景

中国面临着严峻的抗菌药物耐药性(AMR)负担,迄今为止,尚未对中国AMR负担的历史趋势进行全面评估。

方法

全球抗菌药物耐药性负担研究收集了1990 - 2021年的AMR数据。将逻辑回归、多项式模型、堆叠集成模型、时空高斯回归模型和混合效应元回归模型纳入建模框架,以拟合AMR负担,并估计在两种反事实情景下可归因于AMR以及与AMR相关的死亡人数和伤残调整生命年(DALYs)。

结果

2021年,估计中国有711,852例(95%不确定区间[UI](586,447 - 837,256))死亡与细菌AMR相关,其中包括160,268例(132,375 - 188,160)可归因于细菌AMR的死亡。1990年至2021年,5岁以下儿童中可归因于AMR的死亡人数下降了95%,而65岁及以上老年人中的这一数字增加了68%。在12种感染综合征中,2021年因AMR导致死亡人数最多的前三种是血流感染(74,119例)、下呼吸道感染(60,839例)和腹膜及腹腔内感染(11,827例)。其中,血流感染是研究期间死亡人数增加最多的感染综合征。2021年,因AMR导致死亡人数最多的病原体是金黄色葡萄球菌(39,643例),死亡人数增加最多的是金黄色葡萄球菌,增加了20,774例(16,880 - 24,668例)。2021年,导致AMR归因死亡人数最多的病原体 - 药物组合是耐甲氧西林金黄色葡萄球菌(26,023例),31年间归因死亡年化变化率最高的病原体是对第三代头孢菌素耐药的鲍曼不动杆菌(17.5%)。

结论

中国的细菌抗菌药物耐药性对公众健康构成严重威胁,尤其是对老年人。同时,应综合采取普及疫苗接种、减少抗生素滥用和研发新抗生素等干预措施,以应对这一重大健康威胁。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验